TerrAscend Announces $10 Million Share Repurchase Program

1 year ago

TORONTO, Aug. 20, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North…

Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak

1 year ago

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain…

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

1 year ago

SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to…

AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

1 year ago

Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential…

NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University

1 year ago

Celebrating milestones in patient care and practice enhancement through NeuroStar’s innovative training facilityMALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) --…

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

1 year ago

CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical…

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung

1 year ago

NORWOOD, Mass., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced…

Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

1 year ago

SOMERSET, N.J., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell…

Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update

1 year ago

Accelerated the deployment of Nanox ARC in the US market, Submitted a new 510k application to the FDA to expand…

Entera Bio to Participate in Upcoming Investor and Scientific Conferences

1 year ago

JERUSALEM, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the…